Epigenetic targets for immune intervention in human malignancies (Q35551107)

8 August 2017

1 reference

title

Epigenetic targets for immune intervention in human malignancies (English)

1 reference

8 August 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1206956

18 March 2024

Elisabetta Fratta

3

1 reference

ORCID Public Data File 2021

author name string

Michele Maio

1

1 reference

8 August 2017

Sandra Coral

2

1 reference

8 August 2017

Maresa Altomonte

4

1 reference

8 August 2017

Luca Sigalotti

5

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

8 August 2017

29 September 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14528272

full work available at URL

18 March 2024

https://www.nature.com/articles/1206956.pdf

file format

Portable Document Format

1 reference

DOI

https://api.crossref.org/works/10.1038/SJ.ONC.1206956

https://www.nature.com/articles/1206956

18 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1038/SJ.ONC.1206956

18 March 2024

1 reference

8 August 2017

22

1 reference

8 August 2017

42

1 reference

8 August 2017

6484-6488

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1206956

8 August 2017

0 references

cites work

Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

Inhibition of DNA methylation and reactivation of silenced genes by zebularine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

Intracellular adhesion molecule-1 modulates beta-chemokines and directly costimulates T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

DNA methylation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

DNA methylation: an epigenetic pathway to cancer and a promising target for anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

Cancer/testis-associated genes: identification, expression profile, and putative function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

Prolonged Upregulation of the Expression of HLA Class I Antigens and Co stimulatory Molecules on Melanoma Cells Treated with 5-aza-2??-deoxycytidine (5-AZA-CdR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

The role of B7-1/B7-2:CD28/CLTA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

MAGE-A genes are not expressed in human leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

Expression of the MAGE gene family in human head‐and‐neck squamous‐cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

Methylation-regulated expression of HLA class I antigens in melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

Expression of MAGE and BAGE genes in Japanese breast cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

Expression of MAGE genes in human colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

Epigenetic gene silencing in cancer initiation and progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

DNA Methylation and Gene Function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

A cell culture model for T lymphocyte clonal anergy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

HLA class I antigen abnormalities and immune escape by malignant cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

5-Aza-2'-deoxycytidine (decitabine) treatment of hematopoietic malignancies: a multimechanism therapeutic approach?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

Promoter methylation controls the expression of MAGE2, 3 and 4 genes in human cutaneous melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

Expression of SSX genes in human tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

Induction of MAGE-3 expression in lung and esophageal cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206956

7 January 2021

Identifiers

DOI

1 reference

Dimensions Publication ID

8 August 2017

0 references

1 reference